WYNNE HUANG: Open Payments
NPI 1306882741 · WOBURN, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,955 in 143 payments from 19 companies in 2025. Trend: 2023 $4,360 · 2024 $3,573 · 2025 $3,955
Food & beverage: $3,955
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $1,070 |
| Amgen Inc. | 28 | $759 |
| AstraZeneca Pharmaceuticals LP | 24 | $711 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $470 |
| Madrigal Pharmaceuticals | 1 | $131 |
| PFIZER INC. | 6 | $112 |
| Phathom Pharmaceuticals, Inc. | 9 | $102 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $98 |
| Lilly USA, LLC | 4 | $81 |
| Merck Sharp & Dohme LLC | 4 | $79 |
Products named: AIRSUPRA, EVENITY, VRAYLAR, CAPLYTA, BOTOX, REZDIFFRA, Repatha, VOQUEZNA.
Industry payments across MA — which companies pay providers there.
